Moneycontrol PRO
Loans
Loans
HomeNewsBusinessEarningsHold Pfizer: target of Rs 6690: ICICI Direct

Hold Pfizer: target of Rs 6690: ICICI Direct

ICICI Direct recommended hold rating on Pfizer with a target price of Rs 6690 in its research report dated July 29, 2021.

August 02, 2021 / 12:11 IST
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More
    ICICI Direct's research report on Pfizer

    Pfizer collectively addresses 15 therapy areas with a portfolio of over 150 products that include therapeutics & vaccines. The company has been continuously restructuring its portfolio in the last few years to improve the productivity of its core brands Fourth largest multinational pharma company in India Manufacturing facility in Goa with run rate of 1 billion tablets per annum

    Outlook

    We remain positive but change our rating from BUY to HOLD on the stock due to recent run up. We value Pfizer at Rs 6690 i.e. 40x P/E on FY23E EPS

     

    For all recommendations report, click here

    Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

    first published: Aug 2, 2021 12:11 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347